» Authors » Toshihiro Tajima

Toshihiro Tajima

Explore the profile of Toshihiro Tajima including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 146
Citations 1529
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito T, Kumagai H, Kanai T, Aoyagi J, Ono Y, Miura K, et al.
Clin Exp Nephrol . 2025 Jan; PMID: 39821568
Background: Renal fibrosis is strongly correlated with renal functional outcomes. Therefore, this is a significant finding in determining renal prognosis. There are various reports on the imaging evaluation of renal...
2.
Tajima T
Clin Pediatr Endocrinol . 2025 Jan; 34(1):13-18. PMID: 39777132
In Japan, newborn screening (NBS) for congenital adrenal hyperplasia (CAH) began in 1989. NBS is useful for early diagnosis and preventing gender misidentification, however, it has a higher false positive...
3.
Dofuku M, Yano T, Yokoyama K, Okada Y, Kumagai H, Tajima T, et al.
J Pediatr Gastroenterol Nutr . 2025 Jan; 80(3):408-416. PMID: 39760314
Objectives: Patients with Peutz-Jeghers syndrome (PJS) require continuous medical management throughout their lives. However, few case series regarding the clinical course, polyp surveillance, and treatment, including endoscopic ischemic polypectomy (EIP)...
4.
Noda M, Matsumoto A, Ito H, Kagami M, Tajima T, Matsumura T, et al.
Sci Rep . 2024 Dec; 14(1):31911. PMID: 39738362
Growth-associated protein 43 (GAP43) is a membrane-associated phosphoprotein predominantly expressed in the nervous systems, and controls axonal growth, branching, and pathfinding. While the association between GAP43 and human neurological disorders...
5.
Yamagishi H, Osaka H, Muramatsu K, Kojima K, Monden Y, Mitani T, et al.
Sci Rep . 2024 Dec; 14(1):30051. PMID: 39627316
Seizures in patients with developmental and epileptic encephalopathies (DEEs) are often highly resistant to various antiseizure medications. Perampanel (PER) is a novel antiseizure medication that non-competitively inhibits the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid...
6.
Aoyagi J, Kanai T, Ito T, Saito T, Betsui H, Kurosaki M, et al.
Nephrology (Carlton) . 2024 Sep; 29(12):955-959. PMID: 39315463
Kidney transplant (KT) requires long-term glucocorticoid (GC) treatment against acute and/or chronic rejection. Glucocorticoid-induced osteoporosis (GIOP) is one of the major concerns in kidney transplant recipients (KTRs). Therefore, it is...
7.
Nagai K, Mitani T, Kato M, Kojima K, Fukushima N, Omaeuda T, et al.
Pediatr Blood Cancer . 2024 Aug; 71(10):e31228. PMID: 39090683
No abstract available.
8.
Yamagishi H, Tamura D, Yamazaki M, Abe T, Mitamura K, Tajima T, et al.
Viral Immunol . 2024 Jul; 37(6):317-321. PMID: 39001845
It is difficult to differentiate between coronavirus disease 2019 (COVID-19) and influenza based on the symptoms. In the present study, a newly developed antigen rapid diagnostic test (Ag-RDT) called Panbio™...
9.
Okada Y, Kanno A, Sano N, Hashimoto Y, Yokoyama K, Kumagai H, et al.
Pediatr Int . 2024 Jul; 66(1):e15772. PMID: 38978179
No abstract available.
10.
Kanai T, Ito T, Saito T, Aoyagi J, Kurosaki M, Betsui H, et al.
Medicine (Baltimore) . 2024 Jul; 103(27):e38809. PMID: 38968522
In kidney transplant recipients (KTRs), viral infection can lead to antibody and/or T-cell mediated rejection, resulting in kidney transplant dysfunction. Therefore, it is critical to prevent infections. However, KTRs exhibit...